BMJ OPEN 润色咨询

BMJ Open

出版年份:暂无数据 年文章数:27786 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:7.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2181217, encodeId=988a218121efb, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:投了得有大半年了,终于变成awaiting ME decision,看到论坛里说这个阶段估计还需要2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Sat Jan 13 12:56:07 CST 2024, time=2024-01-13, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2184325, encodeId=8e5621843253c, content=这个期刊可不可以共同一作,或者共同通讯作者啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9ca8692425, createdName=ms9000000249269940, createdTime=Sat Jan 27 21:03:49 CST 2024, time=2024-01-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2172047, encodeId=80b021e204773, content=投稿后awaiting reviewer reply和 awaiting reviewer selection状态来回切, 已經兩個月, 要怎樣做?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Thu Nov 30 10:45:04 CST 2023, time=2023-11-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167727, encodeId=89bb216e727e2, content=偏重的研究方向:肿瘤;临床研究;临床<br>经验分享:2023年3月投的,现在都11月了还在外审,整整8个月了,这个等待好漫长,还是希望能收。别这么长时间被拒了,那就直接炸了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8555650732, createdName=三十六爻, createdTime=Fri Nov 10 07:45:51 CST 2023, time=2023-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184822, encodeId=55872184822c3, content=审稿速度:12.0<br>偏重的研究方向:protocol;肿瘤;Meta分析<br>经验分享:肿瘤meta的protocol 2023.3.7投稿,在反复awaiting review reply之后 2023.12.4 major revision 2024.1.4 提交修改稿 2024.1.30 Awaiting ME Decision 不知道还要多久才能有最终结果😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/b9c8799a10a946189ecf1a2c9f00ec70.jpg, type=image, width=1080, height=640)], authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/18/e1f4114b699bf6906d6f9dba9eed5ed7.jpg, createdBy=0ad12272369, createdName=121a9eb0m30暂无昵称, createdTime=Tue Jan 30 13:53:00 CST 2024, time=2024-01-30, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=969650, encodeId=b2e3969650fc, content=偏重的研究方向: 流行病学 <br>经验分享:两次大修后,居然又进入了awaiting reviewer selection的状态。这是怎么回事?重新选择新的审稿人吗?万一和之前审稿人意见不同的话会拒稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun May 30 16:12:35 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997425, encodeId=1d4199e42593, content=请问大家,修稿回去之后,已经完成了reviewer scoring的状态,现在变成了awaiting ME decision,并且收到了邮件说会收到decision letter in due course,这种情况下大概还需要多久能有结果呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3a825521134, createdName=ms3000001348619769, createdTime=Thu Jul 08 08:48:54 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183600, encodeId=304821836005b, content=偏重的研究方向:回顾性研究<br>经验分享:请教一下好心人,12月28大修回去,今天变成Awaiting ME Decision,这个状态需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8555650732, createdName=三十六爻, createdTime=Wed Jan 24 07:44:57 CST 2024, time=2024-01-24, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2124807, encodeId=d74b212480e50, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向:临终关怀;Meta分析;护理<br>经验分享:2022-9月投稿<br>2023-2月大修<br>2023-3月小修<br>一周后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ebf6553884, createdName=ms5000000685090913, createdTime=Mon Apr 10 13:56:14 CST 2023, time=2023-04-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2168981, encodeId=6aca21689816a, content=投稿命中率:50.0<br>偏重的研究方向:protocol;Meta分析<br>经验分享:记录状态,meta分析protocol一篇,23.11.6投稿,23.11.17 awaiting reviewer reply, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Fri Nov 17 10:01:21 CST 2023, time=2023-11-17, status=1, ipAttribution=四川省)]
    2024-01-13 Tina1130 来自香港

    审稿速度:12.0 | 投稿命中率:50.0
    经验分享:投了得有大半年了,终于变成awaiting ME decision,看到论坛里说这个阶段估计还需要2个半月

    23

    展开23条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2181217, encodeId=988a218121efb, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:投了得有大半年了,终于变成awaiting ME decision,看到论坛里说这个阶段估计还需要2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Sat Jan 13 12:56:07 CST 2024, time=2024-01-13, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2184325, encodeId=8e5621843253c, content=这个期刊可不可以共同一作,或者共同通讯作者啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9ca8692425, createdName=ms9000000249269940, createdTime=Sat Jan 27 21:03:49 CST 2024, time=2024-01-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2172047, encodeId=80b021e204773, content=投稿后awaiting reviewer reply和 awaiting reviewer selection状态来回切, 已經兩個月, 要怎樣做?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Thu Nov 30 10:45:04 CST 2023, time=2023-11-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167727, encodeId=89bb216e727e2, content=偏重的研究方向:肿瘤;临床研究;临床<br>经验分享:2023年3月投的,现在都11月了还在外审,整整8个月了,这个等待好漫长,还是希望能收。别这么长时间被拒了,那就直接炸了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8555650732, createdName=三十六爻, createdTime=Fri Nov 10 07:45:51 CST 2023, time=2023-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184822, encodeId=55872184822c3, content=审稿速度:12.0<br>偏重的研究方向:protocol;肿瘤;Meta分析<br>经验分享:肿瘤meta的protocol 2023.3.7投稿,在反复awaiting review reply之后 2023.12.4 major revision 2024.1.4 提交修改稿 2024.1.30 Awaiting ME Decision 不知道还要多久才能有最终结果😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/b9c8799a10a946189ecf1a2c9f00ec70.jpg, type=image, width=1080, height=640)], authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/18/e1f4114b699bf6906d6f9dba9eed5ed7.jpg, createdBy=0ad12272369, createdName=121a9eb0m30暂无昵称, createdTime=Tue Jan 30 13:53:00 CST 2024, time=2024-01-30, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=969650, encodeId=b2e3969650fc, content=偏重的研究方向: 流行病学 <br>经验分享:两次大修后,居然又进入了awaiting reviewer selection的状态。这是怎么回事?重新选择新的审稿人吗?万一和之前审稿人意见不同的话会拒稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun May 30 16:12:35 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997425, encodeId=1d4199e42593, content=请问大家,修稿回去之后,已经完成了reviewer scoring的状态,现在变成了awaiting ME decision,并且收到了邮件说会收到decision letter in due course,这种情况下大概还需要多久能有结果呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3a825521134, createdName=ms3000001348619769, createdTime=Thu Jul 08 08:48:54 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183600, encodeId=304821836005b, content=偏重的研究方向:回顾性研究<br>经验分享:请教一下好心人,12月28大修回去,今天变成Awaiting ME Decision,这个状态需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8555650732, createdName=三十六爻, createdTime=Wed Jan 24 07:44:57 CST 2024, time=2024-01-24, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2124807, encodeId=d74b212480e50, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向:临终关怀;Meta分析;护理<br>经验分享:2022-9月投稿<br>2023-2月大修<br>2023-3月小修<br>一周后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ebf6553884, createdName=ms5000000685090913, createdTime=Mon Apr 10 13:56:14 CST 2023, time=2023-04-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2168981, encodeId=6aca21689816a, content=投稿命中率:50.0<br>偏重的研究方向:protocol;Meta分析<br>经验分享:记录状态,meta分析protocol一篇,23.11.6投稿,23.11.17 awaiting reviewer reply, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Fri Nov 17 10:01:21 CST 2023, time=2023-11-17, status=1, ipAttribution=四川省)]
    2024-01-27 ms9000000249269940 来自北京

    这个期刊可不可以共同一作,或者共同通讯作者啊

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2181217, encodeId=988a218121efb, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:投了得有大半年了,终于变成awaiting ME decision,看到论坛里说这个阶段估计还需要2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Sat Jan 13 12:56:07 CST 2024, time=2024-01-13, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2184325, encodeId=8e5621843253c, content=这个期刊可不可以共同一作,或者共同通讯作者啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9ca8692425, createdName=ms9000000249269940, createdTime=Sat Jan 27 21:03:49 CST 2024, time=2024-01-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2172047, encodeId=80b021e204773, content=投稿后awaiting reviewer reply和 awaiting reviewer selection状态来回切, 已經兩個月, 要怎樣做?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Thu Nov 30 10:45:04 CST 2023, time=2023-11-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167727, encodeId=89bb216e727e2, content=偏重的研究方向:肿瘤;临床研究;临床<br>经验分享:2023年3月投的,现在都11月了还在外审,整整8个月了,这个等待好漫长,还是希望能收。别这么长时间被拒了,那就直接炸了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8555650732, createdName=三十六爻, createdTime=Fri Nov 10 07:45:51 CST 2023, time=2023-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184822, encodeId=55872184822c3, content=审稿速度:12.0<br>偏重的研究方向:protocol;肿瘤;Meta分析<br>经验分享:肿瘤meta的protocol 2023.3.7投稿,在反复awaiting review reply之后 2023.12.4 major revision 2024.1.4 提交修改稿 2024.1.30 Awaiting ME Decision 不知道还要多久才能有最终结果😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/b9c8799a10a946189ecf1a2c9f00ec70.jpg, type=image, width=1080, height=640)], authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/18/e1f4114b699bf6906d6f9dba9eed5ed7.jpg, createdBy=0ad12272369, createdName=121a9eb0m30暂无昵称, createdTime=Tue Jan 30 13:53:00 CST 2024, time=2024-01-30, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=969650, encodeId=b2e3969650fc, content=偏重的研究方向: 流行病学 <br>经验分享:两次大修后,居然又进入了awaiting reviewer selection的状态。这是怎么回事?重新选择新的审稿人吗?万一和之前审稿人意见不同的话会拒稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun May 30 16:12:35 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997425, encodeId=1d4199e42593, content=请问大家,修稿回去之后,已经完成了reviewer scoring的状态,现在变成了awaiting ME decision,并且收到了邮件说会收到decision letter in due course,这种情况下大概还需要多久能有结果呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3a825521134, createdName=ms3000001348619769, createdTime=Thu Jul 08 08:48:54 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183600, encodeId=304821836005b, content=偏重的研究方向:回顾性研究<br>经验分享:请教一下好心人,12月28大修回去,今天变成Awaiting ME Decision,这个状态需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8555650732, createdName=三十六爻, createdTime=Wed Jan 24 07:44:57 CST 2024, time=2024-01-24, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2124807, encodeId=d74b212480e50, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向:临终关怀;Meta分析;护理<br>经验分享:2022-9月投稿<br>2023-2月大修<br>2023-3月小修<br>一周后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ebf6553884, createdName=ms5000000685090913, createdTime=Mon Apr 10 13:56:14 CST 2023, time=2023-04-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2168981, encodeId=6aca21689816a, content=投稿命中率:50.0<br>偏重的研究方向:protocol;Meta分析<br>经验分享:记录状态,meta分析protocol一篇,23.11.6投稿,23.11.17 awaiting reviewer reply, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Fri Nov 17 10:01:21 CST 2023, time=2023-11-17, status=1, ipAttribution=四川省)]
    2023-11-30 ms8000001562779487 来自广东省

    投稿后awaiting reviewer reply和 awaiting reviewer selection状态来回切, 已經兩個月, 要怎樣做?

    2

    展开2条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2181217, encodeId=988a218121efb, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:投了得有大半年了,终于变成awaiting ME decision,看到论坛里说这个阶段估计还需要2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Sat Jan 13 12:56:07 CST 2024, time=2024-01-13, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2184325, encodeId=8e5621843253c, content=这个期刊可不可以共同一作,或者共同通讯作者啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9ca8692425, createdName=ms9000000249269940, createdTime=Sat Jan 27 21:03:49 CST 2024, time=2024-01-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2172047, encodeId=80b021e204773, content=投稿后awaiting reviewer reply和 awaiting reviewer selection状态来回切, 已經兩個月, 要怎樣做?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Thu Nov 30 10:45:04 CST 2023, time=2023-11-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167727, encodeId=89bb216e727e2, content=偏重的研究方向:肿瘤;临床研究;临床<br>经验分享:2023年3月投的,现在都11月了还在外审,整整8个月了,这个等待好漫长,还是希望能收。别这么长时间被拒了,那就直接炸了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8555650732, createdName=三十六爻, createdTime=Fri Nov 10 07:45:51 CST 2023, time=2023-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184822, encodeId=55872184822c3, content=审稿速度:12.0<br>偏重的研究方向:protocol;肿瘤;Meta分析<br>经验分享:肿瘤meta的protocol 2023.3.7投稿,在反复awaiting review reply之后 2023.12.4 major revision 2024.1.4 提交修改稿 2024.1.30 Awaiting ME Decision 不知道还要多久才能有最终结果😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/b9c8799a10a946189ecf1a2c9f00ec70.jpg, type=image, width=1080, height=640)], authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/18/e1f4114b699bf6906d6f9dba9eed5ed7.jpg, createdBy=0ad12272369, createdName=121a9eb0m30暂无昵称, createdTime=Tue Jan 30 13:53:00 CST 2024, time=2024-01-30, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=969650, encodeId=b2e3969650fc, content=偏重的研究方向: 流行病学 <br>经验分享:两次大修后,居然又进入了awaiting reviewer selection的状态。这是怎么回事?重新选择新的审稿人吗?万一和之前审稿人意见不同的话会拒稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun May 30 16:12:35 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997425, encodeId=1d4199e42593, content=请问大家,修稿回去之后,已经完成了reviewer scoring的状态,现在变成了awaiting ME decision,并且收到了邮件说会收到decision letter in due course,这种情况下大概还需要多久能有结果呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3a825521134, createdName=ms3000001348619769, createdTime=Thu Jul 08 08:48:54 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183600, encodeId=304821836005b, content=偏重的研究方向:回顾性研究<br>经验分享:请教一下好心人,12月28大修回去,今天变成Awaiting ME Decision,这个状态需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8555650732, createdName=三十六爻, createdTime=Wed Jan 24 07:44:57 CST 2024, time=2024-01-24, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2124807, encodeId=d74b212480e50, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向:临终关怀;Meta分析;护理<br>经验分享:2022-9月投稿<br>2023-2月大修<br>2023-3月小修<br>一周后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ebf6553884, createdName=ms5000000685090913, createdTime=Mon Apr 10 13:56:14 CST 2023, time=2023-04-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2168981, encodeId=6aca21689816a, content=投稿命中率:50.0<br>偏重的研究方向:protocol;Meta分析<br>经验分享:记录状态,meta分析protocol一篇,23.11.6投稿,23.11.17 awaiting reviewer reply, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Fri Nov 17 10:01:21 CST 2023, time=2023-11-17, status=1, ipAttribution=四川省)]
    2023-11-10 三十六爻

    偏重的研究方向:肿瘤;临床研究;临床
    经验分享:2023年3月投的,现在都11月了还在外审,整整8个月了,这个等待好漫长,还是希望能收。别这么长时间被拒了,那就直接炸了。

    10

    展开10条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2181217, encodeId=988a218121efb, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:投了得有大半年了,终于变成awaiting ME decision,看到论坛里说这个阶段估计还需要2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Sat Jan 13 12:56:07 CST 2024, time=2024-01-13, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2184325, encodeId=8e5621843253c, content=这个期刊可不可以共同一作,或者共同通讯作者啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9ca8692425, createdName=ms9000000249269940, createdTime=Sat Jan 27 21:03:49 CST 2024, time=2024-01-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2172047, encodeId=80b021e204773, content=投稿后awaiting reviewer reply和 awaiting reviewer selection状态来回切, 已經兩個月, 要怎樣做?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Thu Nov 30 10:45:04 CST 2023, time=2023-11-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167727, encodeId=89bb216e727e2, content=偏重的研究方向:肿瘤;临床研究;临床<br>经验分享:2023年3月投的,现在都11月了还在外审,整整8个月了,这个等待好漫长,还是希望能收。别这么长时间被拒了,那就直接炸了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8555650732, createdName=三十六爻, createdTime=Fri Nov 10 07:45:51 CST 2023, time=2023-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184822, encodeId=55872184822c3, content=审稿速度:12.0<br>偏重的研究方向:protocol;肿瘤;Meta分析<br>经验分享:肿瘤meta的protocol 2023.3.7投稿,在反复awaiting review reply之后 2023.12.4 major revision 2024.1.4 提交修改稿 2024.1.30 Awaiting ME Decision 不知道还要多久才能有最终结果😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/b9c8799a10a946189ecf1a2c9f00ec70.jpg, type=image, width=1080, height=640)], authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/18/e1f4114b699bf6906d6f9dba9eed5ed7.jpg, createdBy=0ad12272369, createdName=121a9eb0m30暂无昵称, createdTime=Tue Jan 30 13:53:00 CST 2024, time=2024-01-30, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=969650, encodeId=b2e3969650fc, content=偏重的研究方向: 流行病学 <br>经验分享:两次大修后,居然又进入了awaiting reviewer selection的状态。这是怎么回事?重新选择新的审稿人吗?万一和之前审稿人意见不同的话会拒稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun May 30 16:12:35 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997425, encodeId=1d4199e42593, content=请问大家,修稿回去之后,已经完成了reviewer scoring的状态,现在变成了awaiting ME decision,并且收到了邮件说会收到decision letter in due course,这种情况下大概还需要多久能有结果呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3a825521134, createdName=ms3000001348619769, createdTime=Thu Jul 08 08:48:54 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183600, encodeId=304821836005b, content=偏重的研究方向:回顾性研究<br>经验分享:请教一下好心人,12月28大修回去,今天变成Awaiting ME Decision,这个状态需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8555650732, createdName=三十六爻, createdTime=Wed Jan 24 07:44:57 CST 2024, time=2024-01-24, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2124807, encodeId=d74b212480e50, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向:临终关怀;Meta分析;护理<br>经验分享:2022-9月投稿<br>2023-2月大修<br>2023-3月小修<br>一周后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ebf6553884, createdName=ms5000000685090913, createdTime=Mon Apr 10 13:56:14 CST 2023, time=2023-04-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2168981, encodeId=6aca21689816a, content=投稿命中率:50.0<br>偏重的研究方向:protocol;Meta分析<br>经验分享:记录状态,meta分析protocol一篇,23.11.6投稿,23.11.17 awaiting reviewer reply, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Fri Nov 17 10:01:21 CST 2023, time=2023-11-17, status=1, ipAttribution=四川省)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2181217, encodeId=988a218121efb, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:投了得有大半年了,终于变成awaiting ME decision,看到论坛里说这个阶段估计还需要2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Sat Jan 13 12:56:07 CST 2024, time=2024-01-13, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2184325, encodeId=8e5621843253c, content=这个期刊可不可以共同一作,或者共同通讯作者啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9ca8692425, createdName=ms9000000249269940, createdTime=Sat Jan 27 21:03:49 CST 2024, time=2024-01-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2172047, encodeId=80b021e204773, content=投稿后awaiting reviewer reply和 awaiting reviewer selection状态来回切, 已經兩個月, 要怎樣做?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Thu Nov 30 10:45:04 CST 2023, time=2023-11-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167727, encodeId=89bb216e727e2, content=偏重的研究方向:肿瘤;临床研究;临床<br>经验分享:2023年3月投的,现在都11月了还在外审,整整8个月了,这个等待好漫长,还是希望能收。别这么长时间被拒了,那就直接炸了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8555650732, createdName=三十六爻, createdTime=Fri Nov 10 07:45:51 CST 2023, time=2023-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184822, encodeId=55872184822c3, content=审稿速度:12.0<br>偏重的研究方向:protocol;肿瘤;Meta分析<br>经验分享:肿瘤meta的protocol 2023.3.7投稿,在反复awaiting review reply之后 2023.12.4 major revision 2024.1.4 提交修改稿 2024.1.30 Awaiting ME Decision 不知道还要多久才能有最终结果😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/b9c8799a10a946189ecf1a2c9f00ec70.jpg, type=image, width=1080, height=640)], authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/18/e1f4114b699bf6906d6f9dba9eed5ed7.jpg, createdBy=0ad12272369, createdName=121a9eb0m30暂无昵称, createdTime=Tue Jan 30 13:53:00 CST 2024, time=2024-01-30, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=969650, encodeId=b2e3969650fc, content=偏重的研究方向: 流行病学 <br>经验分享:两次大修后,居然又进入了awaiting reviewer selection的状态。这是怎么回事?重新选择新的审稿人吗?万一和之前审稿人意见不同的话会拒稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun May 30 16:12:35 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997425, encodeId=1d4199e42593, content=请问大家,修稿回去之后,已经完成了reviewer scoring的状态,现在变成了awaiting ME decision,并且收到了邮件说会收到decision letter in due course,这种情况下大概还需要多久能有结果呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3a825521134, createdName=ms3000001348619769, createdTime=Thu Jul 08 08:48:54 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183600, encodeId=304821836005b, content=偏重的研究方向:回顾性研究<br>经验分享:请教一下好心人,12月28大修回去,今天变成Awaiting ME Decision,这个状态需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8555650732, createdName=三十六爻, createdTime=Wed Jan 24 07:44:57 CST 2024, time=2024-01-24, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2124807, encodeId=d74b212480e50, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向:临终关怀;Meta分析;护理<br>经验分享:2022-9月投稿<br>2023-2月大修<br>2023-3月小修<br>一周后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ebf6553884, createdName=ms5000000685090913, createdTime=Mon Apr 10 13:56:14 CST 2023, time=2023-04-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2168981, encodeId=6aca21689816a, content=投稿命中率:50.0<br>偏重的研究方向:protocol;Meta分析<br>经验分享:记录状态,meta分析protocol一篇,23.11.6投稿,23.11.17 awaiting reviewer reply, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Fri Nov 17 10:01:21 CST 2023, time=2023-11-17, status=1, ipAttribution=四川省)]
    2021-05-30 wkw0722

    偏重的研究方向: 流行病学
    经验分享:两次大修后,居然又进入了awaiting reviewer selection的状态。这是怎么回事?重新选择新的审稿人吗?万一和之前审稿人意见不同的话会拒稿吗?

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2181217, encodeId=988a218121efb, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:投了得有大半年了,终于变成awaiting ME decision,看到论坛里说这个阶段估计还需要2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Sat Jan 13 12:56:07 CST 2024, time=2024-01-13, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2184325, encodeId=8e5621843253c, content=这个期刊可不可以共同一作,或者共同通讯作者啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9ca8692425, createdName=ms9000000249269940, createdTime=Sat Jan 27 21:03:49 CST 2024, time=2024-01-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2172047, encodeId=80b021e204773, content=投稿后awaiting reviewer reply和 awaiting reviewer selection状态来回切, 已經兩個月, 要怎樣做?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Thu Nov 30 10:45:04 CST 2023, time=2023-11-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167727, encodeId=89bb216e727e2, content=偏重的研究方向:肿瘤;临床研究;临床<br>经验分享:2023年3月投的,现在都11月了还在外审,整整8个月了,这个等待好漫长,还是希望能收。别这么长时间被拒了,那就直接炸了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8555650732, createdName=三十六爻, createdTime=Fri Nov 10 07:45:51 CST 2023, time=2023-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184822, encodeId=55872184822c3, content=审稿速度:12.0<br>偏重的研究方向:protocol;肿瘤;Meta分析<br>经验分享:肿瘤meta的protocol 2023.3.7投稿,在反复awaiting review reply之后 2023.12.4 major revision 2024.1.4 提交修改稿 2024.1.30 Awaiting ME Decision 不知道还要多久才能有最终结果😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/b9c8799a10a946189ecf1a2c9f00ec70.jpg, type=image, width=1080, height=640)], authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/18/e1f4114b699bf6906d6f9dba9eed5ed7.jpg, createdBy=0ad12272369, createdName=121a9eb0m30暂无昵称, createdTime=Tue Jan 30 13:53:00 CST 2024, time=2024-01-30, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=969650, encodeId=b2e3969650fc, content=偏重的研究方向: 流行病学 <br>经验分享:两次大修后,居然又进入了awaiting reviewer selection的状态。这是怎么回事?重新选择新的审稿人吗?万一和之前审稿人意见不同的话会拒稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun May 30 16:12:35 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997425, encodeId=1d4199e42593, content=请问大家,修稿回去之后,已经完成了reviewer scoring的状态,现在变成了awaiting ME decision,并且收到了邮件说会收到decision letter in due course,这种情况下大概还需要多久能有结果呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3a825521134, createdName=ms3000001348619769, createdTime=Thu Jul 08 08:48:54 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183600, encodeId=304821836005b, content=偏重的研究方向:回顾性研究<br>经验分享:请教一下好心人,12月28大修回去,今天变成Awaiting ME Decision,这个状态需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8555650732, createdName=三十六爻, createdTime=Wed Jan 24 07:44:57 CST 2024, time=2024-01-24, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2124807, encodeId=d74b212480e50, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向:临终关怀;Meta分析;护理<br>经验分享:2022-9月投稿<br>2023-2月大修<br>2023-3月小修<br>一周后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ebf6553884, createdName=ms5000000685090913, createdTime=Mon Apr 10 13:56:14 CST 2023, time=2023-04-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2168981, encodeId=6aca21689816a, content=投稿命中率:50.0<br>偏重的研究方向:protocol;Meta分析<br>经验分享:记录状态,meta分析protocol一篇,23.11.6投稿,23.11.17 awaiting reviewer reply, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Fri Nov 17 10:01:21 CST 2023, time=2023-11-17, status=1, ipAttribution=四川省)]
    2021-07-08 ms3000001348619769

    请问大家,修稿回去之后,已经完成了reviewer scoring的状态,现在变成了awaiting ME decision,并且收到了邮件说会收到decision letter in due course,这种情况下大概还需要多久能有结果呢

    7

    展开7条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2181217, encodeId=988a218121efb, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:投了得有大半年了,终于变成awaiting ME decision,看到论坛里说这个阶段估计还需要2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Sat Jan 13 12:56:07 CST 2024, time=2024-01-13, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2184325, encodeId=8e5621843253c, content=这个期刊可不可以共同一作,或者共同通讯作者啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9ca8692425, createdName=ms9000000249269940, createdTime=Sat Jan 27 21:03:49 CST 2024, time=2024-01-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2172047, encodeId=80b021e204773, content=投稿后awaiting reviewer reply和 awaiting reviewer selection状态来回切, 已經兩個月, 要怎樣做?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Thu Nov 30 10:45:04 CST 2023, time=2023-11-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167727, encodeId=89bb216e727e2, content=偏重的研究方向:肿瘤;临床研究;临床<br>经验分享:2023年3月投的,现在都11月了还在外审,整整8个月了,这个等待好漫长,还是希望能收。别这么长时间被拒了,那就直接炸了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8555650732, createdName=三十六爻, createdTime=Fri Nov 10 07:45:51 CST 2023, time=2023-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184822, encodeId=55872184822c3, content=审稿速度:12.0<br>偏重的研究方向:protocol;肿瘤;Meta分析<br>经验分享:肿瘤meta的protocol 2023.3.7投稿,在反复awaiting review reply之后 2023.12.4 major revision 2024.1.4 提交修改稿 2024.1.30 Awaiting ME Decision 不知道还要多久才能有最终结果😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/b9c8799a10a946189ecf1a2c9f00ec70.jpg, type=image, width=1080, height=640)], authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/18/e1f4114b699bf6906d6f9dba9eed5ed7.jpg, createdBy=0ad12272369, createdName=121a9eb0m30暂无昵称, createdTime=Tue Jan 30 13:53:00 CST 2024, time=2024-01-30, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=969650, encodeId=b2e3969650fc, content=偏重的研究方向: 流行病学 <br>经验分享:两次大修后,居然又进入了awaiting reviewer selection的状态。这是怎么回事?重新选择新的审稿人吗?万一和之前审稿人意见不同的话会拒稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun May 30 16:12:35 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997425, encodeId=1d4199e42593, content=请问大家,修稿回去之后,已经完成了reviewer scoring的状态,现在变成了awaiting ME decision,并且收到了邮件说会收到decision letter in due course,这种情况下大概还需要多久能有结果呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3a825521134, createdName=ms3000001348619769, createdTime=Thu Jul 08 08:48:54 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183600, encodeId=304821836005b, content=偏重的研究方向:回顾性研究<br>经验分享:请教一下好心人,12月28大修回去,今天变成Awaiting ME Decision,这个状态需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8555650732, createdName=三十六爻, createdTime=Wed Jan 24 07:44:57 CST 2024, time=2024-01-24, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2124807, encodeId=d74b212480e50, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向:临终关怀;Meta分析;护理<br>经验分享:2022-9月投稿<br>2023-2月大修<br>2023-3月小修<br>一周后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ebf6553884, createdName=ms5000000685090913, createdTime=Mon Apr 10 13:56:14 CST 2023, time=2023-04-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2168981, encodeId=6aca21689816a, content=投稿命中率:50.0<br>偏重的研究方向:protocol;Meta分析<br>经验分享:记录状态,meta分析protocol一篇,23.11.6投稿,23.11.17 awaiting reviewer reply, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Fri Nov 17 10:01:21 CST 2023, time=2023-11-17, status=1, ipAttribution=四川省)]
    2024-01-24 三十六爻 来自甘肃省

    偏重的研究方向:回顾性研究
    经验分享:请教一下好心人,12月28大修回去,今天变成Awaiting ME Decision,这个状态需要多长时间?

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2181217, encodeId=988a218121efb, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:投了得有大半年了,终于变成awaiting ME decision,看到论坛里说这个阶段估计还需要2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Sat Jan 13 12:56:07 CST 2024, time=2024-01-13, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2184325, encodeId=8e5621843253c, content=这个期刊可不可以共同一作,或者共同通讯作者啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9ca8692425, createdName=ms9000000249269940, createdTime=Sat Jan 27 21:03:49 CST 2024, time=2024-01-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2172047, encodeId=80b021e204773, content=投稿后awaiting reviewer reply和 awaiting reviewer selection状态来回切, 已經兩個月, 要怎樣做?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Thu Nov 30 10:45:04 CST 2023, time=2023-11-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167727, encodeId=89bb216e727e2, content=偏重的研究方向:肿瘤;临床研究;临床<br>经验分享:2023年3月投的,现在都11月了还在外审,整整8个月了,这个等待好漫长,还是希望能收。别这么长时间被拒了,那就直接炸了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8555650732, createdName=三十六爻, createdTime=Fri Nov 10 07:45:51 CST 2023, time=2023-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184822, encodeId=55872184822c3, content=审稿速度:12.0<br>偏重的研究方向:protocol;肿瘤;Meta分析<br>经验分享:肿瘤meta的protocol 2023.3.7投稿,在反复awaiting review reply之后 2023.12.4 major revision 2024.1.4 提交修改稿 2024.1.30 Awaiting ME Decision 不知道还要多久才能有最终结果😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/b9c8799a10a946189ecf1a2c9f00ec70.jpg, type=image, width=1080, height=640)], authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/18/e1f4114b699bf6906d6f9dba9eed5ed7.jpg, createdBy=0ad12272369, createdName=121a9eb0m30暂无昵称, createdTime=Tue Jan 30 13:53:00 CST 2024, time=2024-01-30, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=969650, encodeId=b2e3969650fc, content=偏重的研究方向: 流行病学 <br>经验分享:两次大修后,居然又进入了awaiting reviewer selection的状态。这是怎么回事?重新选择新的审稿人吗?万一和之前审稿人意见不同的话会拒稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun May 30 16:12:35 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997425, encodeId=1d4199e42593, content=请问大家,修稿回去之后,已经完成了reviewer scoring的状态,现在变成了awaiting ME decision,并且收到了邮件说会收到decision letter in due course,这种情况下大概还需要多久能有结果呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3a825521134, createdName=ms3000001348619769, createdTime=Thu Jul 08 08:48:54 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183600, encodeId=304821836005b, content=偏重的研究方向:回顾性研究<br>经验分享:请教一下好心人,12月28大修回去,今天变成Awaiting ME Decision,这个状态需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8555650732, createdName=三十六爻, createdTime=Wed Jan 24 07:44:57 CST 2024, time=2024-01-24, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2124807, encodeId=d74b212480e50, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向:临终关怀;Meta分析;护理<br>经验分享:2022-9月投稿<br>2023-2月大修<br>2023-3月小修<br>一周后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ebf6553884, createdName=ms5000000685090913, createdTime=Mon Apr 10 13:56:14 CST 2023, time=2023-04-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2168981, encodeId=6aca21689816a, content=投稿命中率:50.0<br>偏重的研究方向:protocol;Meta分析<br>经验分享:记录状态,meta分析protocol一篇,23.11.6投稿,23.11.17 awaiting reviewer reply, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Fri Nov 17 10:01:21 CST 2023, time=2023-11-17, status=1, ipAttribution=四川省)]
    2023-04-10 ms5000000685090913 来自湖南省

    审稿速度:6.0 | 投稿命中率:75.0
    偏重的研究方向:临终关怀;Meta分析;护理
    经验分享:2022-9月投稿
    2023-2月大修
    2023-3月小修
    一周后接受

    3

    展开3条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2181217, encodeId=988a218121efb, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:投了得有大半年了,终于变成awaiting ME decision,看到论坛里说这个阶段估计还需要2个半月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200804/b240f936e21e44bfbd965bfd8e0d8598/7ff50448cc364484b0350107a115d287.jpg, createdBy=66a35286254, createdName=Tina1130, createdTime=Sat Jan 13 12:56:07 CST 2024, time=2024-01-13, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2184325, encodeId=8e5621843253c, content=这个期刊可不可以共同一作,或者共同通讯作者啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9ca8692425, createdName=ms9000000249269940, createdTime=Sat Jan 27 21:03:49 CST 2024, time=2024-01-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2172047, encodeId=80b021e204773, content=投稿后awaiting reviewer reply和 awaiting reviewer selection状态来回切, 已經兩個月, 要怎樣做?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89015638805, createdName=ms8000001562779487, createdTime=Thu Nov 30 10:45:04 CST 2023, time=2023-11-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2167727, encodeId=89bb216e727e2, content=偏重的研究方向:肿瘤;临床研究;临床<br>经验分享:2023年3月投的,现在都11月了还在外审,整整8个月了,这个等待好漫长,还是希望能收。别这么长时间被拒了,那就直接炸了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8555650732, createdName=三十六爻, createdTime=Fri Nov 10 07:45:51 CST 2023, time=2023-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2184822, encodeId=55872184822c3, content=审稿速度:12.0<br>偏重的研究方向:protocol;肿瘤;Meta分析<br>经验分享:肿瘤meta的protocol 2023.3.7投稿,在反复awaiting review reply之后 2023.12.4 major revision 2024.1.4 提交修改稿 2024.1.30 Awaiting ME Decision 不知道还要多久才能有最终结果😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/b9c8799a10a946189ecf1a2c9f00ec70.jpg, type=image, width=1080, height=640)], authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/18/e1f4114b699bf6906d6f9dba9eed5ed7.jpg, createdBy=0ad12272369, createdName=121a9eb0m30暂无昵称, createdTime=Tue Jan 30 13:53:00 CST 2024, time=2024-01-30, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=969650, encodeId=b2e3969650fc, content=偏重的研究方向: 流行病学 <br>经验分享:两次大修后,居然又进入了awaiting reviewer selection的状态。这是怎么回事?重新选择新的审稿人吗?万一和之前审稿人意见不同的话会拒稿吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d1aa4732935, createdName=wkw0722, createdTime=Sun May 30 16:12:35 CST 2021, time=2021-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997425, encodeId=1d4199e42593, content=请问大家,修稿回去之后,已经完成了reviewer scoring的状态,现在变成了awaiting ME decision,并且收到了邮件说会收到decision letter in due course,这种情况下大概还需要多久能有结果呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3a825521134, createdName=ms3000001348619769, createdTime=Thu Jul 08 08:48:54 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183600, encodeId=304821836005b, content=偏重的研究方向:回顾性研究<br>经验分享:请教一下好心人,12月28大修回去,今天变成Awaiting ME Decision,这个状态需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8555650732, createdName=三十六爻, createdTime=Wed Jan 24 07:44:57 CST 2024, time=2024-01-24, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2124807, encodeId=d74b212480e50, content=审稿速度:6.0 | 投稿命中率:75.0<br>偏重的研究方向:临终关怀;Meta分析;护理<br>经验分享:2022-9月投稿<br>2023-2月大修<br>2023-3月小修<br>一周后接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ebf6553884, createdName=ms5000000685090913, createdTime=Mon Apr 10 13:56:14 CST 2023, time=2023-04-10, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2168981, encodeId=6aca21689816a, content=投稿命中率:50.0<br>偏重的研究方向:protocol;Meta分析<br>经验分享:记录状态,meta分析protocol一篇,23.11.6投稿,23.11.17 awaiting reviewer reply, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/STQuHjjJKMYl69lTpXIUI5u3woQuKskqLpsia8jC0M8lfDTTISjic4ekEeDKYQ6B3iaedCtqiaQicAn2lKENsicHAsIQ/132, createdBy=a36c2405777, createdName=ssssdsfwaefwa, createdTime=Fri Nov 17 10:01:21 CST 2023, time=2023-11-17, status=1, ipAttribution=四川省)]
    2023-11-17 ssssdsfwaefwa 来自四川省

    投稿命中率:50.0
    偏重的研究方向:protocol;Meta分析
    经验分享:记录状态,meta分析protocol一篇,23.11.6投稿,23.11.17 awaiting reviewer reply

    8

    展开8条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分